Zelluna Immunotherapy

Zelluna Immunotherapy

Pre-clinical
Oslo, Norwayzelluna.com

Zelluna is pioneering novel cell therapies for the treatment of cancer patients.

Founded
2016
Focus
BiologicsCell & Gene Therapy

About

Zelluna is pioneering novel cell therapies for the treatment of cancer patients.

Funding History

2

Total raised: $26.5M

Series A$20MKorea Investment PartnersMar 15, 2023
Seed$6.5MUndisclosedJun 15, 2021

Company Info

TypePrivate
Founded2016
LocationOslo, Norway
StagePre-clinical
SIMILAR COMPANIES
Algipharma
Algipharma
Phase 1 · Bergen
Bio-Me
Bio-Me
Pre-clinical · Oslo
CardiNor
CardiNor
Pre-clinical · Oslo
Gentian USA
Gentian USA
Pre-clinical · Moss
Hemispherian
Hemispherian
Phase 1 · Oslo
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile